Quick Links

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Exelixis, Inc. and Merck & Co., Inc.

Privacy Policy
Terms & Conditions
Executive Board
Faculty Portal
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2019
Physicians’ Education Resource ®, LLC.
All rights reserved.

ASCO: Leveraging Evolving Data Sets to Inform Treatment Decision-Making in Advanced RCC: An Expert Tumor Board Discussion

ASCO: Leveraging Evolving Data Sets to Inform Treatment Decision-Making in Advanced RCC: An Expert Tumor Board Discussion

Saturday, June 1, 2019

Hilton Chicago
International Ballroom North
720 S Michigan Ave
Chicago, IL 60605

Dinner and Registration: 6:30 PM – 7:00 PM
Scientific Session: 7:00 PM – 9:00 PM


Leveraging Evolving Data Sets to Inform Treatment Decision-Making in Advanced RCC: An Expert Tumor Board Discussion is a live symposium that will be held adjunct to the 2019 ASCO annual meeting in Chicago. This activity will bring together internationally renowned experts in the treatment of patients with advanced renal cell carcinoma (RCC). Please join this esteemed faculty for an in-depth discussion on the clinical impact of recent and emerging trial data for monotherapies and combination approaches in RCC using a “real-world” tumor board format. A series of tightly integrated case presentations will illuminate RCC treatment decisions related to sequencing and switching based on patient and disease characteristics. Adverse events and their management will be a part of the discussion. Additionally, future directions in the field will be addressed and considered in the context of how recent developments and highly anticipated trials may soon shape future patient care. Don’t miss this exciting opportunity to improve your practice!

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the biologic rationale for use of targeted agents and immunotherapies, as single agents and in combination, to treat renal cell carcinoma (RCC)
  • Analyze practice-changing and emerging data from clinical trials of systemic therapies for use across multiple lines of therapy for advanced RCC
  • Integrate knowledge of the safety profile of systemic therapies and best practices to proactively identify and mitigate treatment-related toxicities during treatment planning for patients with metastatic RCC
  • Consider the efficacy and safety of single-agent and combination systemic therapies, as well as patient and disease characteristics and patient preferences, as a part of shared decision-making for patients with metastatic RCC

Target Audience

This educational program is directed toward medical oncologists, surgical oncologists, and radiation oncologists interested in the treatment of renal cell carcinoma. Urologists, nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with renal cell carcinoma are also invited to participate.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Exelixis, Inc. and Merck & Co., Inc.


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.    

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information



Become a Member

Forgot Password?
Calendar of Events
Filter By